Enhanced taxane uptake into bladder tissues following co-administration with either mitomycin C, doxorubicin or gemcitabine: association to exfoliation processes-Reference-Cited by-同舟云学术

Enhanced taxane uptake into bladder tissues following co-administration with either mitomycin C, doxorubicin or gemcitabine: association to exfoliation processes

Published:2018-07-27 Issue:5 Volume:122 Page:898-908
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Pandey Rakhi¹^ORCID,Jackson John K.¹,Liggins Richard²,Mugabe Clement²,Burt Helen M.¹

Affiliation:

1. Pharmaceutical Science; The University of British Columbia; Vancouver BC Canada

2. Centre for Drug Research and Development; The University of British Columbia; Vancouver BC Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14423/fullpdf

Reference49 articles.

1. National Cancer Institute (SEER Program) Cancer Stat Facts: Bladder Cancer 2018 https://seer.cancer.gov/statfacts/html/urinb.html

2. International Agency for Research on Cancer World Cancer Report 2014 http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2014

3. Guideline of guidelines: non-muscle-invasive bladder cancer;Woldu;BJU Int,2017

4. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

5. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer;Journal of Urology;2022-09

2. Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer;Clinical Genitourinary Cancer;2022-09

3. Advancements in Intravesical Chemotherapy in Non-Muscle Invasive Bladder Cancer;Modern Approach to Diagnosis and Treatment of Bladder Cancer;2021-11-24

4. Smart nanocarriers as therapeutic platforms for bladder cancer;Nano Research;2021-09-21

5. Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non–muscle-invasive bladder cancer: Pro;European Urology Focus;2021-09